Publications by authors named "Rosemary J Froehlich"
Article Synopsis
- Organophosphate esters (OPEs), commonly used in flame retardants and plasticizers, may negatively impact pregnancy outcomes, including lower birth rates and higher preterm deliveries, due to their potential endocrine-disrupting effects.
- This pilot study involved 56 mother-infant pairs, measuring the relationships between maternal OPE metabolites and various pregnancy and infant growth metrics, including gestational weight gain and infant feeding behaviors.
- Results indicated weak positive correlations between OPE levels and gestational weight gain, along with BDCPP being linked to greater infant length and weight in males, as well as heightened food responsiveness.
Objective: To assess treatment outcomes associated with an obstetric hypertensive emergency quality improvement intervention instituted in a tertiary care women's emergency department.
Methods: We conducted a cohort study of pregnant (20 weeks of gestation or greater) and postpartum (6 weeks of gestation or less) women treated for hypertensive emergency (systolic blood pressure [BP] 160 mm Hg or greater, diastolic 110 mm Hg or greater, or both) before and after a quality improvement intervention. A multidisciplinary task force revised clinical guidelines and nursing policy, updated electronic order sets, and provided staff education and clinical management aids.
The objective of this study was to evaluate the rate of abnormal fetal echocardiogram after normal detailed anatomy ultrasound when both are performed by maternal-fetal medicine specialists. Retrospective review of women who underwent detailed anatomy ultrasound and fetal echocardiography between 16 and 26 weeks' gestation at a single center. Women included had at least one indication for fetal echocardiography as recommended by the American Institute of Ultrasound in Medicine and normal cardiac anatomy on initial detailed anatomy ultrasound.
View Article and Find Full Text PDFThe Potential Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus.
Am J Perinatol
November 2016
More than 9% of overweight and obese women develop gestational diabetes mellitus (GDM) during pregnancy. Myoinositol is a promising supplement that may represent the first GDM-risk modifier that could be implemented on a population-level. It has been shown in animal and small human trials to prevent GDM through its insulin-mimetic properties.
View Article and Find Full Text PDFObjective: To evaluate the association between documentation of estimated fetal weight, and its value, with cesarean delivery.
Methods: This was a secondary analysis of a multicenter observational cohort of 115,502 deliveries from 2008 to 2011. Data were abstracted by trained and certified study personnel.